Recommendations for the aesthetic evaluation of breast cancer conservative treatment Maria João CardosoJaime Santos CardosoMohammed Keshtgar Review 04 February 2012 Pages: 629 - 637
Metformin and breast cancer risk: a meta-analysis and critical literature review Nananda F. ColLeslie OchsRowan T. Chlebowski Review 31 July 2012 Pages: 639 - 646
Excess body weight and second primary cancer risk after breast cancer: a systematic review and meta-analysis of prospective studies Nathalie Druesne-PecolloMathilde TouvierPaule Latino-Martel Review 05 August 2012 Pages: 647 - 654
Lapatinib, trastuzumab or the combination added to preoperative chemotherapy for breast cancer: a meta-analysis of randomized evidence Antonis ValachisAndreas NearchouDavide Mauri Review 09 August 2012 Pages: 655 - 662
Body composition changes in females treated for breast cancer: a review of the evidence Patricia M. SheeanKent HoskinsMelinda Stolley Review 19 August 2012 Pages: 663 - 680
The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancer Rabia A. GilaniArmina A. KaziAngela H. Brodie Preclinical Study 10 August 2012 Pages: 681 - 692
Is there ‘progression through grade’ in ductal invasive breast cancer? Barbara SchymikHorst BuergerEberhard Korsching Preclinical Study 12 August 2012 Pages: 693 - 703
Diagnostic values of GHSR DNA methylation pattern in breast cancer Sandeep Kumar BotlaAmin Moghaddas GholamiYasser Riazalhosseini Preclinical Study 17 August 2012 Pages: 705 - 713
Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians Jingxuan ShanWijden MahfoudhLotfi Chouchane Preclinical Study Open access 22 August 2012 Pages: 715 - 724
Expression of CXCL14 and its anticancer role in breast cancer Xiao-Li GuZhou-Luo OuZhi-Ming Shao Preclinical study 22 August 2012 Pages: 725 - 735
Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production Zhi ShiWei-Min YangRuo-Pan Huang Preclinical Study 26 August 2012 Pages: 737 - 747
Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein M. Victoria GoddioAlbana GattelliEdith C. Kordon Preclinical study 29 August 2012 Pages: 749 - 758
An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancer Hui LiSara Duhachek-MuggyAnna Zolkiewska Preclinical study 29 August 2012 Pages: 759 - 769
RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model Jude CanonRebecca BryantWilliam C. Dougall Preclinical Study 29 August 2012 Pages: 771 - 780
Sentinel lymph node biopsy at the time of mastectomy does not increase the risk of lymphedema: implications for prophylactic surgery Cynthia L. MillerMichelle C. SpechtAlphonse G. Taghian Preclinical Study 01 September 2012 Pages: 781 - 789
Reducing vasomotor symptoms with acupuncture in breast cancer patients treated with adjuvant tamoxifen: a randomized controlled trial Annelie LiljegrenPia GunnarssonSamuel Rotstein Clinical trial 14 December 2010 Pages: 791 - 798
Advanced cognitive training for breast cancer survivors: a randomized controlled trial Diane Von AhJanet S. CarpenterFred Unverzagt Clinical Trial 24 August 2012 Pages: 799 - 809
Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physicians Falk C. ThielMichael G. SchrauderMichael P. Lux Clinical trial 30 August 2012 Pages: 811 - 820
Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study Saroj NiraulaRyan J. O. DowlingPamela J. Goodwin Clinical Trial 30 August 2012 Pages: 821 - 830
Improving size, lymph node metastatic rate, breast conservation, and mortality of invasive breast cancer in Rhode Island women, a well-screened population Natalie G. CoburnBlake CadyMaureen A. Chung Clinical Trial 30 August 2012 Pages: 831 - 837
Predicting sentinel lymph node metastasis in a Chinese breast cancer population: assessment of an existing nomogram and a new predictive nomogram Jia-ying ChenJia-jian ChenJiong Wu Clinical trial 01 September 2012 Pages: 839 - 848
Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer Babette Siebold SaltzmanKathleen E. MaloneChristopher I. Li Epidemiology 19 August 2012 Pages: 849 - 855
Small airways function in breast cancer patients before and after radiotherapy Sylvia VerbanckShane HanonWalter Vincken Epidemiology 22 August 2012 Pages: 857 - 865
Is the prevalence of ER-negative breast cancer in the US higher among Africa-born than US-born black women? Ahmedin JemalStacey A. Fedewa Epidemiology 23 August 2012 Pages: 867 - 873
Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study Peter A. KaufmanAdam M. BrufskyDenise A. Yardley Epidemiology Open access 26 August 2012 Pages: 875 - 883
Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer Katharina HeusingerSebastian M. JudDavid L. Wachter Epidemiology 31 August 2012 Pages: 885 - 892
Receipt of locoregional therapy among young women with breast cancer Rachel A. FreedmanKatherine S. VirgoNancy L. Keating Epidemiology 05 September 2012 Pages: 893 - 906
Preoperative breast MRI in early-stage breast cancer Patricia YoungBenjamin KimJennifer L. Malin Brief Report 26 August 2012 Pages: 907 - 912
Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors Laura A. PetrilloDenise M. WolfLaura J. Esserman Brief Report 02 September 2012 Pages: 913 - 922
Erratum to: 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1 Eitan AmirReena S. CecchiniPamela J. Goodwin Erratum 05 August 2012 Pages: 923 - 923
Erratum to: Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways Catherine Ibarra-DrendallMichelle M. TrochVictoria L. Seewaldt Erratum 31 August 2012 Pages: 925 - 925
